The very nature of traditional Chinese medicine (TCM) poses serious challenges in patenting intellectual property. Unlike modern medicines, which are based on newly discovered, developed or isolated chemical compounds, TCM prescriptions typically consist of mixtures of well-known plant or animal extracts. Moreover, these recipes are public knowledge, having been recorded in ancient books, and are therefore ineligible for patents in areas where a compound's novelty is a prerequisite.

Cholesterol Drug Hits US Stores The Day Pfizer Loses Patent Protection

Lipitor goes off patent today, but Pfizer may’ve queered pitch for clones, impacting Ranbaxy-led Indian pharma

Approval draws criticism over transparency and safety tests.

Tiered pricing - the concept of selling drugs and vaccines in developing countries at prices systematically lower than in industrialized countries - has received widespread support from industry, policymakers, civil society, and academics as a way to improve access to medicines for the poor. We carried out case studies based on a review of international drug price developments for antiretrovirals, artemisinin combination therapies, drug-resistant tuberculosis medicines, liposomal amphotericin B (for visceral leishmaniasis), and pneumococcal vaccines.

The National Pharmaceuticals Pricing Policy 2011 presently seeks to limit itself to the central objective of promulgating the principles for pricing of Essential Drugs as laid down in the “National List of Essential Medicines ‐ 2011” as declared

The biotechnology industry has had its share of woes, but so far 'patent trolls' have not numbered among them. These companies, which profit by legally enforcing patents they own rather than developing products, may benefit from a 31 August ruling at a US federal court of appeal in Washington DC.

A scientist from city-based National Chemical Laboratory (NCL), Dattatraya H Dethe, has been selected for the Organisation of Pharmaceutical Producers of India (OPPI) Young Scientist award 2011 for

Monsanto Co., the world's largest seed company, has prevailed in another lawsuit against a U.S.

A simplification of the US patent system is good news for inventors, but could have gone further. (Editorial)